NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) PCT Platform Featured in ProCan Scientific Team’s Sample Preparation Protocol

December 18, 2018 15:37:44

Pressure BioSciences (OTCQB: PBIO) today announced that a Centre for the Proteome of Human Cancer (“ProCan”) scientific team has published a recommended sample preparation protocol built around PBIO’s Barocycler instrument system, which is designed to improve diagnosis and treatment of cancers through optimizing the identification and use of novel biomarkers. Per the update, ProCan scientists have named the new protocol Accelerated Barocycler Lysis and Extraction (“ABLE”), which is based on PBIO’s proprietary pressure cycling technology (“PCT”) platform for the rapid breakup of tissue samples and release of molecules for analysis. “We are pleased that ProCan has developed an advanced sample processing system, featuring the use of our Barocycler instrument system,” PBIO Senior VP and Chief Commercial Officer Dr. Bradford Young stated in the news release. “The ABLE method will enable scientists worldwide to benefit from the advantages of our PCT platform technology for cancer profiling and drug development, as reported by ProCan scientists and their colleagues. We believe the ABLE method has the potential to help transform the way cancer is diagnosed and treated for improved patient outcomes.”

To view the full press release, visit

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office